---
stable_id: R-HSA-5658438
display_name: SPRED dimer binds NF1
species: Homo sapiens
summary: 'Sprouty-related proteins (SPRED) 1, 2 and 3 are negative regulators of the
  MAPK pathway that act at least in part by recruiting the RAS GAP protein neurofibromin
  1 (NF1) to the plasma membrane (Kato et al, 2003; King et al, 2006; Stowe et al,
  2012). NF1, a negative regulator of RAS is a tumor suppressor that is mutated in
  the familial cancer syndrome neurofibromatosis I as well as in sporadic cases of
  glioblastoma, non-small cell lung cancers, neuroblastoma and melanoma (Martin et
  al, 1990; Bollag et al, 1996; reviewed in Bollag and McCormick, 1992; Maertens and
  Cichowski, 2014).<br><br>Plasma membrane-association of the SPRED proteins themselves
  depends on the C-terminal SPR domain.  Mutations in this region abrogate membrane
  localization of the protein (King et al, 2005; Stowe et al, 2012).  Membrane association
  may also be promoted by interaction of the SPRED proteins with RAS (Wakioka et al,
  2001).  Interaction with NF1 is mediated by the SPRED EVH1 domain, and mutations
  in this region affect both NF1 recruitment and the ability of SPRED and NF1 proteins
  to negatively regulate RAS pathway activity (Stowe et al, 2012; reviewed in McClatchey
  and Cichowski, 2012).  '
---

# SPRED dimer binds NF1
**Reactome ID:** [R-HSA-5658438](https://reactome.org/content/detail/R-HSA-5658438)
**Species:** Homo sapiens

## Summary

Sprouty-related proteins (SPRED) 1, 2 and 3 are negative regulators of the MAPK pathway that act at least in part by recruiting the RAS GAP protein neurofibromin 1 (NF1) to the plasma membrane (Kato et al, 2003; King et al, 2006; Stowe et al, 2012). NF1, a negative regulator of RAS is a tumor suppressor that is mutated in the familial cancer syndrome neurofibromatosis I as well as in sporadic cases of glioblastoma, non-small cell lung cancers, neuroblastoma and melanoma (Martin et al, 1990; Bollag et al, 1996; reviewed in Bollag and McCormick, 1992; Maertens and Cichowski, 2014).<br><br>Plasma membrane-association of the SPRED proteins themselves depends on the C-terminal SPR domain.  Mutations in this region abrogate membrane localization of the protein (King et al, 2005; Stowe et al, 2012).  Membrane association may also be promoted by interaction of the SPRED proteins with RAS (Wakioka et al, 2001).  Interaction with NF1 is mediated by the SPRED EVH1 domain, and mutations in this region affect both NF1 recruitment and the ability of SPRED and NF1 proteins to negatively regulate RAS pathway activity (Stowe et al, 2012; reviewed in McClatchey and Cichowski, 2012).  
